[Use of an anxiolytic agent (lorazepam) in low doses in the treatment of anxiety states].
A nonblind clinical study was carried out by administering Lorazepam at a low dosage to patients with a light to moderate state of reactive anxiety. The drug was shown to be effective in the management of the target symptoms studied: anorexia, sleep induction, rhythm, and duration disturbances, depression, irritability and moodiness, fatigue, anxiety and tension, somatic anxiety, social adaptation. The results obtained are practically identical to those reported in the literature for higher doses. Moreover, low-dose Lorazepam was well tolerated and without undesired side-effects.
D000328:Adult; D000368:Aged; D014151:Anti-Anxiety Agents / Q000008:administration & dosage*; D001007:Anxiety / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008140:Lorazepam / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged
D014151:Anti-Anxiety Agents; D008140:Lorazepam
Sull'uso di un ansiolitico ("lorazepam") a basso dosaggio nella terapia degli stati ansiosi.